Estazolam is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mayne Pharma. The primary component is Estazolam.
| Product ID | 51862-069_5c2c3362-4980-4acb-8271-1f26847720d9 |
| NDC | 51862-069 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Estazolam |
| Generic Name | Estazolam |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-08-03 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA074921 |
| Labeler Name | Mayne Pharma |
| Substance Name | ESTAZOLAM |
| Active Ingredient Strength | 1 mg/1 |
| Pharm Classes | Benzodiazepine [EPC],Benzodiazepines [CS] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2016-08-03 |
| Marketing End Date | 2022-05-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA074921 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-08-03 |
| Ingredient | Strength |
|---|---|
| ESTAZOLAM | 1 mg/1 |
| SPL SET ID: | b22148fd-8b86-496c-a540-d8af20cb8a12 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0591-0744 | Estazolam | Estazolam |
| 0591-0745 | Estazolam | Estazolam |
| 21695-220 | Estazolam | Estazolam |
| 51862-069 | Estazolam | Estazolam |
| 51862-070 | Estazolam | Estazolam |
| 51862-073 | Estazolam | Estazolam |
| 51862-074 | Estazolam | Estazolam |
| 70954-480 | Estazolam | Estazolam |
| 70954-481 | Estazolam | Estazolam |